ImmunityBio, Inc. IBRX Proceeds from secured term loan
Proceeds from secured term loan at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSecuredDebt.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s proceeds from secured term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ImmunityBio, Inc.'s proceeds from secured term loan?
- ImmunityBio, Inc. (IBRX) reported proceeds from secured term loan of $75M in Q1 2026.
- What does proceeds from secured term loan mean?
- Cash inflows resulting from the issuance of debt instruments backed by specific company assets. This metric highlights the company's ability to leverage its asset base to secure external financing.